ANALYST COVERAGE

Oppenheimer maintained an Outperform rating on Abeona Therapeutics Inc. (ABEO) and raised its price target to $22 on…

Oppenheimer maintained an Outperform on Trevi Therapeutics, Inc. (TRVI) on March 09, 2026 after a 10% near-term share…

MSFT analyst rating update: William Blair reiterated Outperform and Barclays kept Overweight on Microsoft Corporation on March 09,…

Leerink Partners on March 09, 2026 maintained its Market Perform rating on BioMarin Pharmaceutical Inc. (BMRN). The BMRN…

Joel South Mon, March 9, 2026 at 11:28 AM EDT 4 min read H World (HTHT) upgraded to…

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions…

24/7 Wall St. (24/7 Wall St.) Quick Read H World (HTHT) upgraded to Buy by UBS, $62.40 target,…

Wolfe Research initiates Cava stock coverage with outperform rating

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

Couloir Capital updated research coverage on Roxmore Resources (OTCQX: GARLF) on March 9, 2026, highlighting the Converse Gold…

This is a paid press release. Contact the press release distributor directly with any inquiries. TMX Newsfile Mon,…

UBS maintained its Buy rating for Oshkosh Corporation (OSK) on March 06, 2026, and raised the price target…